64 results
8-K
EX-99.1
ALKS
Alkermes plc
7 Mar 24
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
7:09am
brings decades of pharmaceutical and biotechnology industry leadership experience and strong commercial expertise, including a track record … leadership, governance, strategic planning, product development and commercialization. This broad expertise will be an important asset to the Board
8-K
ALKS
Alkermes plc
8 Dec 23
Departure of Directors or Certain Officers
4:05pm
reasons, from the Company’s board of directors (the “Board”) and from any Board leadership positions and committees on which she serves, in each case
DFAN14A
dejepo8jju 5hu
26 Jun 23
Additional proxy materials by non-management
5:00pm
DEFA14A
apiovel mvog
26 Jun 23
Additional proxy soliciting materials
4:45pm
DFAN14A
px5ju3cbkatxbommy
22 Jun 23
Additional proxy materials by non-management
4:33pm
DFAN14A
wi1zgy
20 Jun 23
Additional proxy materials by non-management
4:30pm
DEFA14A
giuyfdfdy
13 Jun 23
Additional proxy soliciting materials
7:08am
DEFA14A
ewj650
12 Jun 23
Additional proxy soliciting materials
9:00am
DEFA14A
zuacfz4aaid5sb
7 Jun 23
Additional proxy soliciting materials
5:28pm
DEFC14A
tuudbylgro0sztc w32
2 Jun 23
Proxy in contested solicitation
3:09pm
DEFA14A
vi1t 6soc11ngylwo
25 May 23
Additional proxy soliciting materials
4:31pm
DEFC14A
if8zicl53g uj
25 May 23
Proxy in contested solicitation
4:03pm
PRRN14A
98dp1f
22 May 23
Revised preliminary proxy statement filed by non-management
5:15pm
PRER14A
r8k1nta
19 May 23
Preliminary revised proxy
5:23pm
PREC14A
utnv6o9j6fvozfr0i
15 May 23
Preliminary proxy with contested solicitation
8:45am
DEFA14A
EX-99.1
bbyc9ep
8 May 23
Additional proxy soliciting materials
5:11pm